ALK Positive Inc. shared on LinkedIn:
“The stage is set! We’re thrilled to announce Dr. Stephen Liu as the keynote speaker for the 2026 ALK+ Summit.
Dr. Liu is a globally recognized thoracic oncologist, researcher, and passionate advocate for advancing lung cancer care. His dedication to improving outcomes through cutting-edge research and compassionate patient care has made him a trusted leader in the lung cancer community.
Whether you’re newly diagnosed, living with ALK-positive lung cancer, a care partner, or simply looking to learn from the world’s leading oncologists, you won’t want to miss his inspiring keynote.
Can’t join us in Washington, D.C.? You can still be part of the experience from anywhere in the world by registering for our live virtual Summit.
We can’t wait to bring our global ALK-positive community together for an unforgettable weekend of education, connection, hope, and progress.”
Read also Sacituzumab Tirumotecan Plus Pembrolizumab Meets Phase III Endpoint in First-Line PD-L1-Negative Non-Squamous NSCLC on OncoDaily.
